Scientific Skincare: Firn Breaks Through with Smart Strategy
Parijs, woensdag, 2 juli 2025.
Sacha Bostoni, co-founder of Jimmy Fairly, launches Firn, an advanced cosmetics brand that combines scientific expertise with affordable products. The brand distinguishes itself by developing the Thirty Days Stem Cell Complex (STM30), an innovative ingredient targeting skin improvement. With a sharp positioning - high-quality products at reasonable prices - Firn plans to open two of its own stores in Paris by the end of 2025. The first collection includes a Multi-Corrective Cream and five serums, with 85-99.9% natural ingredients, targeting different skin types and maintaining a socially responsible approach by donating 1% of revenue to farmers.
Founding of Firn: An Innovative Beauty Strategy
Sacha Bostoni, the former co-founder of Jimmy Fairly, launches Firn, a cosmetics brand that combines scientific expertise with affordable skincare products [1]. After his partial withdrawal from Jimmy Fairly two years ago, Bostoni sees parallels between the current beauty market and the eyewear market: a ‘noisy’ environment with a poorly differentiated shopping experience [2].
Scientific Innovation in Skincare
The brand introduces the Thirty Days Stem Cell Complex (STM30), a unique ingredient developed by Dr. Fred Zülli that targets wrinkles, dark circles, and skin hydration [2]. The brand name Firn is derived from a Swiss-German word for recrystallised snow on a glacier, where the used microorganisms were originally discovered [2].
Product Range and Pricing Strategy
Firn launches with a Multi-Corrective Cream and five serums, with products priced at 3,667 euros per 50 ml and 15 ml respectively [2]. The formulas contain between 85% and 99.9% natural ingredients, with a social commitment of donating 1% of revenue to farming communities [2].
Distribution and Future Plans
The products will initially be exclusively available via Oh My Cream online, followed by their own digital platform in September and two own stores in Paris by November 2025 [2].